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Background: Hepatitis C is not only a globally prevalent disease but also a significant cause of death. It has 
multiple complications ranging from Hepatocellular carcinoma to decompensated liver disease. This study was 
planned to determine the frequencies of various risk factors in Hepatitis C positive patients presenting to a 
tertiary care health facility in Rawalpindi. 
Material and Methods: This descriptive, cross-sectional study included 394 patients that presented to Liver 
Centre, Holy Family Hospital during the years 2015 to 2016. All these patients were confirmed cases of Hepatitis 
C. The data were collected from records of the liver center of Holy Family Hospital, Rawalpindi. Statistical 
Package for Social Sciences (SPSS), version 23 was used to analyze data, and descriptive statistics were calculated. 
All patients with any other comorbidity were excluded. 
Results: Of the 394 patients included in this study, 197 (50%) males and 197(50%) females with an average age of 
44.48. Out of these, 143(36.3%) had a history of previous surgery, 65 (16.5%) had a blood transfusion, 165 (42.19%) 
had a history of dental treatment, and 189(48.0%) had a history of injections (IM and IV). Ninety-two patients 
(23.4%) had a history of barber shave, four patients (1%) had tattooing, and 83 patients (21.1 %) had a history of 
ear piercing. Fifty patients (38.2%) had a family history of Hepatitis C. Only 23 (31.2%) patients had only one risk 
factor, while 271 (68.7%) had more than one risk factor before a diagnosis of disease. 
Conclusion: The majority of the patients had more than one risk factor, with a history of injection use being the 
most common (intravenous and intramuscular). It was followed by the history of dental treatment, family history, 
and history of previous surgery. 
Keywords: Hepatitis C, risk factors, surgery, blood transfusion, dental treatment.  
  
38                                            Student Supplement of Journal of Rawalpindi Medical College (SJRMC); 2020; 24(1): 37-41  
Introduction 
 
Hepatitis C is a significant cause of chronic liver 
disease and Hepatocellular carcinoma. Worldwide, 
170 million people suffer from Hepatitis C virus 
according to World Health Organization.1 
Hepatitis C can spread from person to person. A 
person suffering from hepatitis C virus can end up 
having any of the severe outcomes like chronic liver 
disease, liver cirrhosis, and eventually, liver cancer 
within a period as short as 20 years or more. Data 
shows that the acute infection of HCV has resulted in 
54,000 cases of deaths and 955,000 cases of morbidity; 
however, it is the chronicity that causes a significant 
burden.2,3 
Besides lack of effective HCV vaccine, blood 
transfusion without prior screening, standard 
tattooing practices and that too without any aseptic 
measures, use of unsterile syringes and injections for 
drugs, unsafe sex have significantly contributed to 
increased risk of infection.4,5 
According to a study conducted by Nelson et al, 60-
80% of IV drug abusers in 26 countries had anti-HCV.6 
The increase in use of intranasal cocaine for 
recreational purposes, especially among the younger 
generation, has exposed them to HCV infection as its 
use probably promotes passage through vessels of the 
nasal septum.7 
The development of tests for HCV surrogate markers 
in developed countries and screening for blood 
transfusion has dramatically reduced the risk of 
Hepatitis C virus transmission to 0.001% per unit of 
transfused blood.8 Due to a lack of proper care and 
negligence in adopting optimal precautions, HCV is 
more likely to have a nosocomial transmission in 
developing countries. Unfortunately, in Pakistan, the 
risk of Hepatitis C virus transmission via blood 
transfusion is still high. Organ transplant and 
hemodialysis patients, infants born to HCV‐infected 
mothers, health care workers are also at great risk.9 
According to a study, transmission via therapeutic 
injections, tattooing, shaving at barbers' shops, and 
ear‐piercing required further investigation.10 
Poor socio-economic conditions eventually lead to 
overcrowding, where non-infected family members 
have to live with HCV infected family members 
without any appropriate precautions. Such conditions 
add up to the already increased risk of transmission in 
developing countries. Household items like nail 
clippers, razor blades, toothbrushes, when shared, can 
also lead to virus transmission.11 However, still, there 
are many cases in which the source is not known.12 
Although different researches had been conducted in 
Pakistan to evaluate and assess the various risk factors 
of HCV in the past, this research will provide more 
updated data, which will help the local authorities and 
infection control departments in our community to use 
this information in controlling the spread of this 
infection and devising ways to prevent its spread in 
future.  
The objective of this study is to determine the 
frequencies of various risk factors in Hepatitis C 
positive patients presenting to a tertiary health care 
facility in Rawalpindi.  
 
Materials and Methods 
 
This retrospective cross-sectional descriptive study 
was conducted on 394 consecutive Hepatitis C virus-
infected patients who presented at Liver Centre of 
Holy Family Hospital, Rawalpindi from 2015-2016. 
Approval was taken from the institutional research 
forum before conducting the study. Using an 
anticipated proportion of 0.095, 95% confidence 
interval, and 0.05 absolute precision, the minimally 
required sample size according to the WHO sample 
size calculator was calculated to be 380, but 394 
participants were included.  
Patients of both genders who were confirmed cases of 
hepatitis C and above 18 years of age were included in 
the study after obtaining informed consent from them. 
While those with any other comorbidity or liver 
disease and history of alcohol use were excluded. 
Their data were obtained from the hospital record. 
Information regarding hospital identity number, 
gender, age, marital status, and the risk factors was 
recorded on a self-designed questionnaire which also 
included questions regarding any history of blood 
transfusion, surgical procedure, dental procedure, 
injections, sexual contact, ear piercing, tattooing, 
barber shave, or any family history of Hepatitis C 
infection. 
Data were entered and analyzed using the statistical 
software program Statistical Package for Social 
Sciences, SPSS version 22. Qualitative variables like 
gender and each risk factor are presented as 
frequencies and percentages, while quantitative 
variables like age are presented as means and 
standard deviation. 
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Results 
 
Out of the 394 patients, 197 (50%) were males, and 197 
(50%) were females. The age of our patients ranged 
from 20 years to 90 years, with a mean age of 44.48 ± 
11.96 years. One hundred and fifty patients (38.1%) 
had a positive family history of Hepatitis C infection. 
Further details about the patients are shown in Table 
1. 
 
Table 1: Characteristics of patients 
Characteristics Number of patients 
Age  
Mean age 44.48 ± 11.96 years 
< 30 years old 100 
31 – 45 years old 174 




Region of residence  
Rawalpindi 140 
Other areas of Punjab 184 




Bilirubin level  4.63±5.6 mg/dl 
Baseline ALT levels 1302.8 ± 865.2 IU/ml 
 
Only 23 (31.2%) patients had only one risk factor, 
while 271 (68.7%) had more than one risk factor before 
hepatitis C diagnosis. Results showed injection use as 
the most common risk factor, with 189 (48%) patients 
having a positive history. Among them, 92 were 
males, and 97 were females. Dental procedures were 
the second most common risk factor, followed by 
surgery, history of shave by the barber, ear piercing, 
and blood transfusion. Details about the risk factors 
are mentioned in Table 2. 
 
Table 2: Table showing the frequencies of risk 
factors of Hepatitis C in the sample population 
Risk factors N (% of patients) 
Injection use 189 (48%) 
Dental treatment 167 (42.4%) 
History of surgical 
procedures 
143 (36.3%) 
Barber shave 92 (23.4%) 
Ear piercing 83 (21.1%) 
Blood transfusion 65 (16.5%) 
Sexual contact with a 
HCV infected person 
19 (4.8%) 




It is seen that due to HCV, chronic liver disease and 
Hepatocellular Carcinoma is high in Pakistan.13 
Among the provinces in Pakistan, Punjab, which is the 
most populated, is leading in the prevalence of 
Hepatitis in Pakistan.14 
Hepatitis C is a significant cause of illness and death 
worldwide. 15 Its prevalence varies across regions and 
populations.16 Hepatitis C infection is highly 
prevalent, but very few cases come under medical 
attention.  Thus, the underlying disease burden is 
massive, as many cases are not reported.17,18  
In this research, data were collected from 394 patients. 
Possible risk factors like injection use, dental 
procedures, surgical procedures, blood transfusion, 
sexual contact, family relation, barber shave, ear 
piercing, and tattooing were considered in both sexes 
separately. 
Prevalence of Hepatitis C increases with increasing 
age. Our research also showed the mean age of 
Hepatitis C patients to be 44. It can be correlated with 
a study done in the United States that showed that the 
highest rate of infection was observed among the age 
group of 45-49 years old individuals.19 
According to one study, the majority of patients had a 
classic parenteral transmission risk factor.20 This is 
consistent with our results where injection abuse (both 
IM and IV) turned out to be the major risk factor. 
Injections could be a very potent risk factor in 
transmitting HCV infection if used without taking 
appropriate precautions. An increase in the patients' 
demand for injections due to common misconceptions 
like the injection pain is somehow related to greater 
efficacy, was also observed in a study.21 It was 
estimated that around 12 billion injections were given 
per year worldwide, and in some South-East regions, 
80% of injections used might not be sterile. Pakistan, 
also a developing country, has a higher proportion of 
injections given per prescription. SIGN (Safe Injection 
Global Network) at the WHO recommends controlling 
their overuse, ensuring proper sterilization and 
disposal guidelines as three ways to reduce infection 
by injectables.22 
In another research conducted on the Han population, 
blood transfusion, operation and acupuncture were 
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determined as important risk factors with prevalence 
being 27.64 and 12.7% respectively.23 In comparison to 
it, our results showed their prevalence as 16.5% and 
36.3%, respectively. Thus, Blood transfusion is also a 
significant risk factor. Blood donations in Pakistan are 
mostly done in replacement by the relatives and 
friends of the patient.24 To ensure safe transfusion, 
proper selection of donors and their screening is 
necessary.25 
Our study showed that razor shaving and ear piercing 
as important risk factors with 23.4% and 21.1% 
frequency, respectively. A positive history of barber 
shaving was found only in males. One study revealed 
that in developing countries, the barbers do not 
sterilize their tools as they do not have sufficient 
knowledge regarding the transmission of infectious 
disease and that is why they do not take any safety 
measures.26 It also showed that ear piercing was 
mostly a risk factor for females, as it can also be 
because of use of non-sterile instruments.26 
Transmission of Hepatitis C through family members 
and vertical transmission are also observed. In 
Pakistan, vertical transmission was observed in 8.6% 
of pregnant women in the Hazara division and in 1.8 
% of pregnant women in Karachi.27 However, our 
research showed only 38.1% of patients with positive 
family history.28 
A study in Ethiopia showed a history of 
hospitalization, tooth extraction and, blood 
transfusion to be major risk factors.29 Hospital-based 
factors like dental procedures, injection abuse and 
other surgical procedures act as substantial risk factors 
for HCV transmission.30-34 This is consistent with our 
research with injection abuse, dental procedures and 
surgical procedures being the top three contributing 
risk factors. 
Hepatitis C infection is a serious disease which cannot 
be ignored. Knowledge about its transmission and risk 
factors can help in combating and preventing this 
disease. Therefore, public awareness is essential for 
this purpose. More research is required to be 
conducted in our region, and adequate measures need 




This study concludes that most patients have more 
than one risk factor, with a history of injection use 
(intravenous and intramuscular) being the most 
common. It was followed by the history of dental 
treatment, family history, some surgical intervention 
in the past, history of the shave by the barber, ear 
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